Antonini, M. et al. 2026. Updated meta-analysis of randomized trials: pathological complete response as a prognostic marker for survival in breast cancer treated with neoadjuvant chemotherapy. Mastology. 35, suppl.1 (Feb. 2026). DOI:https://doi.org/10.29289/259453942025V35S1009.